U.S. markets closed

$200+ Billion Worldwide Infection Prevention & Control Market to 20207 - Impact of COVID-19

DUBLIN, June 17, 2020 /PRNewswire/ -- The "Infection Prevention & Control - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The Global Infection Prevention & Control market accounted for $139.59 billion in 2018 and is expected to reach $224.08 billion by 2027 growing at a CAGR of 5.4% during the forecast period. Some of the key factors propelling the market growth include increased adoption of contract sterilization and in-house sterilization procedures, increase in incidence of hospital acquired infections (HAIS), growing number of surgical procedures, rising number of government initiatives, and rapidly growing geriatric population. However, low level of vaccination among healthcare workers is likely to hamper the market.

Infection prevention and control is the most important and significant step in the development and maintenance of products in the medical devices, pharmaceuticals, and food industries. It is to prevent the transmission of communicable disease. For the prevention of any infection one should have the basic understanding of the infection and the risk of the infection. Infection prevention and control system includes the necessary products to prevent the cross infection from equipment, surface and skin of patient and healthcare staff.

By products & services equipment, the personal protective equipment segment is anticipated to grow at a significant rate during the forecast period. With the growth in prevention and control concerns of various health associated infections, personal protective equipment's. To control various types of cross-infections in hospitals and clinics also there has been a growth of personal protective equipment's market globally. Demand for better quality care in hospitals and other healthcare establishments is forcing the hospitals to invest in quality medical protective wear and other accessories has also acted as a key factor in the growth of this segment.

On the basis of geography, North America region is anticipated to have considerable market growth during the forecast period, due to rising prevalence of the nosocomial infection and stringent regulation followed by the hospitals, clinicians and care givers aligning with regulatory bodies. With the increase in the number of death due to Antibiotic-resistant infections, by contrast it is anticipated that there will be a growth in IP&C Market in the regions of North America.

Some of the key players in infection prevention & control market include Danaher Corporation, Johnson & Johnson, Becton, Dickinson, and Company, 3M Company, Baxter International, Ansell Limited, Belimed AG, Aquionics, Bemis Company Incorporated, Abbott, Braun (B.) Melsungen AG, Cantel Medical Corporation, Cardinal Health Incorporated, Covidien, Henkel, Simens, Getinge Group, Hollister, Medtronics, and CCP Industries.

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Key Topics Covered:

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Infection Prevention & Control Market, By Antimicrobial Drugs
5.1 Introduction
5.2 Anti-Fungal Drugs
5.3 Vaccines
5.4 Anti-Bacterial Drugs
5.5 Anti-Viral Drugs

6 Global Infection Prevention & Control Market, By Infection Type
6.1 Introduction
6.2 Healthcare Associated Infections
6.2.1 Community Acquired Infection
6.2.1.1 Community Acquired Pneumonia (CAP)
6.2.1.2 Methicillin Resistant Staphylococcus Aureus (MRSA) Infection
6.2.2 Hospital Acquired Infection
6.2.2.1 Surgical Site Infection
6.2.2.2 Ventilator Associated Pneumonia (VAP) Infection
6.2.2.3 Central Line Associated Bloodstream Infection (CLABSI)
6.2.2.4 Catheter Associated Urinary Tract Infection
6.3 Microbial infections
6.3.1 Fungal Infections
6.3.1.1 Cryptococcus Gatti
6.3.1.2 Aspergillis
6.3.1.3 Pneumocystis Pneumonia (PCP)
6.3.1.4 Dermatophytes
6.3.1.5 Gungal Keratitis
6.3.1.6 Exserohilum
6.3.1.7 Cladosporium
6.3.2 Viral Infections
6.3.2.1 Herpes Simplex Virus
6.3.2.2 Yellow Fever
6.3.2.3 Dengue Viruses
6.3.2.4 Ebola Virus
6.3.2.5 Junin Virus
6.3.2.6 KFD (Kyasanur Forest Virus)
6.3.2.7 Machupo Virus
6.3.2.8 Human Immunodeficiency Virus (HIV)
6.3.3 Clostridium Difficile Infections
6.3.3.1 Escherichia Coli Infections
6.3.3.2 Helicobacter Pylori
6.3.3.3 Salmonella
6.3.4 Exserohilum
6.3.5 Bacterial Infections
6.3.5.1 Mycobacterium Tuberculosis

7 Global Infection Prevention & Control Market, By Products & Services Equipment
7.1 Introduction
7.2 Infection Prevention Supplies
7.2.1 Disinfectants
7.2.1.1 Surgical Disinfectants
7.2.1.2 Environmental Disinfectants
7.2.1.3 Surface Disinfectants
7.2.1.4 Instrument Disinfectants
7.2.1.5 Skin Disinfectants
7.2.1.6 Hand Sanitizers
7.2.1.7 Disinfectants Wipes
7.2.2 Autoclave
7.2.2.1 Horizontal Autoclave
7.2.2.2 Portable Autoclave
7.2.2.3 Vertical Autoclave
7.2.3 Personal Protective Equipment
7.2.3.1 Medical & Laboratory Gloves
7.2.3.1.1 Examination Gloves
7.2.3.1.2 Surgical Gloves
7.2.3.1.3 Laboratory Gloves
7.2.3.2 Surgical Masks & Respirators
7.2.3.3 Surgical Foot Covers
7.2.3.4 Surgical Drapes
7.2.3.4.1 Nonwoven Drapes
7.2.3.4.2 Plastic Drapes
7.2.3.4.3 Woven Drapes
7.2.3.5 Surgical Gowns
7.2.3.6 Patient Gowns
7.2.3.7 Surgical & Staff Face Masks
7.2.3.8 Other Personal Protective Equipment
7.2.3.8.1 Disposable Staff Apparel
7.2.3.8.2 Disposable Towels & Bedding
7.2.4 Safety-Enhanced Medical Devices
7.2.4.1 Safety-Enhanced Syringes
7.2.4.1.1 Prefillable Syringes
7.2.4.1.2 Safety-Enhanced Clinical Syringes
7.2.4.2 Safety-Enhanced Catheters
7.2.4.2.1 IV Catheters
7.2.4.2.2 Urinary Catheters
7.2.4.3 Safety-Enhanced Blood Collection Tubes
7.2.5 Sterilization Supplies
7.2.5.1 Sterile Containers
7.2.5.2 Sterilization Wrap
7.2.5.3 Sterilization Indicators
7.2.6 Medical Waste Disposal Supplies
7.2.6.1 Medical Waste Disposal Containers
7.2.6.2 Medical Waste Disposal Accessories
7.3 Infection Prevention Equipment
7.3.1 Sterilization Equipment
7.3.1.1 Sterilization Technologies
7.3.1.1.1 Filtration Sterilization
7.3.1.1.2 Radiation Sterilization
7.3.1.1.3 Low Temperature Sterilization
7.3.1.1.3.1 In-House Steam Sterilization
7.3.1.1.3.2 Ethylene Oxide (EO) Sterilization
7.3.1.1.3.3 Gamma and e-Beam Sterilization
7.3.1.1.4 Wet/Stream Sterilization
7.3.1.1.5 Dry Heat Sterilization
7.3.1.1.6 Contract Sterilization Services
7.3.2 Washing/Disinfecting Equipment
7.3.3 Endoscope Reprocessors
7.3.4 Other Infection Prevention Equipment
7.3.4.1 Infectious Waste Receptacles
7.3.4.2 Infectious Waste Processing Units

8 Global Infection Prevention & Control Market, By End User
8.1 Introduction
8.2 Drug Usage
8.2.1 Individuals & Patients
8.2.2 Nursing & Senior care Centers
8.3 Equipment Usage
8.3.1 Medical Laboratories
8.3.2 Manufacturing Units
8.3.2.1 Pharmaceuticals
8.3.2.2 Medical Devices
8.3.2.3 Food & Beverages Industry
8.3.3 Hospitals & Clinics
8.3.4 Life Science Industry

9 Global Infection Prevention & Control Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Danaher Corporation
11.2 Johnson & Johnson
11.3 Becton, Dickinson, and Company
11.4 3M Company
11.5 Baxter International
11.6 Ansell Limited
11.7 Belimed AG
11.8 Aquionics
11.9 Bemis Company Incorporated
11.10 Abbott
11.11 Braun (B.) Melsungen AG
11.12 Cantel Medical Corporation
11.13 Cardinal Health Incorporated
11.14 Covidien
11.15 Henkel
11.16 Simens
11.17 Getinge Group
11.18 Hollister
11.19 Medtronics
11.20 CCP Industries

For more information about this report visit https://www.researchandmarkets.com/r/aulmz9

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision

View original content:http://www.prnewswire.com/news-releases/200-billion-worldwide-infection-prevention--control-market-to-20207---impact-of-covid-19-301078928.html

SOURCE Research and Markets